## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.46 indicates fundamental undervaluation. Quality metrics strong (ROE 15%). Consistent execution (4/4 quarters beat estimates). Caution: overbought RSI (74).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($229.30)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 3, Bearish: 1)

**1. AIZ SEC Filings - Assurant 10-K, 10-Q, 8-K Forms**
- Source: Stock Titan | 20251216T100756 | Neutral | Relevance: 100%
- This page provides a comprehensive resource for Assurant (AIZ) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. Stock Titan's AI-powered platform translates these legal documents into plain language, offering summaries of key financial data and real-time alerts on insider transactions. Recent filings discuss registered offerings, prospectus supplements for new notes to redeem existing debt, and insider stock disposals by executives.

**2. Assurant stock hits all-time high of 232.45 USD**
- Source: Investing.com India | 20251216T060727 | Bullish | Relevance: 100%
- Assurant Inc. (AIZ) stock recently reached an all-time high of $232.45, reflecting strong investor confidence and robust performance including 22 consecutive years of dividend increases. The company reported impressive Q3 2025 results, exceeding EPS and revenue forecasts, and announced a new $700 million share repurchase program and a 10% dividend hike. Analysts from Keefe, Bruyette & Woods and BMO Capital have raised their price targets, indicating a positive outlook for Assurant's continued growth and shareholder value enhancement.

**3. Is Assurant Stock Underperforming the Nasdaq?**
- Source: Markets Financial Content | 20251217T120755 | Bullish | Relevance: 100%
- Assurant, Inc. (AIZ) has shown mixed performance compared to the Nasdaq Composite ($NASX). While AIZ stock gained 13.6% in the past three months, outperforming NASXâ€™s 3.5%, it underperformed in the longer term with 7.4% gains over 52 weeks against NASX's 14.6%. Analysts maintain a "Moderate Buy" rating for AIZ, projecting an 8.7% upside.

**4. Assurant stock hits all-time high of 232.45 USD By Investing.com**
- Source: Investing.com Australia | 20251216T090754 | Bullish | Relevance: 100%
- Assurant Inc. (AIZ) stock reached an all-time high of $232.45, reflecting strong investor confidence and robust market performance. The company's stock has increased by 6.52% over the past year, supported by 22 consecutive years of dividend increases and a current dividend yield of 1.54%. Recent third-quarter 2025 results surpassed expectations, leading to a new $700 million share repurchase program and a 10% dividend increase, with analysts raising price targets on the stock.

**5. Is Assurant Stock Underperforming the Nasdaq?**
- Source: Barchart.com | 20251217T123343 | Somewhat-Bullish | Relevance: 99%
- Assurant, Inc. (AIZ) has shown mixed performance compared to the Nasdaq Composite. While AIZ shares have outperformed the Nasdaq Composite ($NASX) over the past three months, gaining 13.6% compared to NASX's 3.5%, its longer-term performance lags, with AIZ up 7.4% over 52 weeks versus NASX's 14.6%. Analysts have a "Moderate Buy" rating for AIZ, with a mean price target suggesting an 8.7% upside.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Keefe, Bruyette | $254 | $248 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Keefe, Bruyette | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 0.57 |
| 52W Range | $174.97 - $240.58 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 11.4 |
| Current P/E | 12.2 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 1.5% to 5.5% (+4.0% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 85th percentile. MRS_5 at 1.6% confirms short-term momentum alignment. AM_20 at 4.8% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.14), confirming momentum. RSI overbought at 74, risk of mean reversion. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.51% (CS: 85) | Strong |
| RSI_14 | 73.5 | Overbought |
| MACD Histogram | 1.14 | Bullish |
| vs SMA20 | 1.047x | Above |
| vs SMA50 | 1.076x | Above |
| vs SMA200 | 1.152x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $237.92
- **Stop Loss:** $229.30 (3.6% risk)
- **Target:** $255.16 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 82
- **Position Value:** $19,509.44
- **Portfolio %:** 19.51%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*